Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Phase II Study of Lutetium Lu 177 Dotatate (LUTATHERA®) in Patients With Inoperable, Progressive Meningioma After External Beam Radiation Therapy

NCT04082520 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT04082520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04082520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Phase II Study of Lutetium Lu 177 Dotatate (LUTATHERA®) in Patients With Inoperable, Progressive Meningioma After External Beam Radiation Therapy
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Recruiting
Start date
April 14, 2020
Completion date
March 4, 2032
Enrollment
42 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

grade 1 meningioma, grade 2 meningioma, grade 3 meningioma, recurrent meningioma, unresectable meningioma